Clinical Trials Directory

Trials / Completed

CompletedNCT05426122

Degree of Digestibility of Barley Rice Proteins

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Wageningen University and Research · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study aims to assess the degree of digestibility of barley rice protein and compare this to another sustainable, commercially available protein concentrate (pea protein), and a benchmark whey protein, and to assess the effects on blood glucose and insulin levels. The study is a randomized, cross-over, double blind, controlled trial. Three different treatments, all representing a 20g protein load, will be evaluated with a washout period of minimum one week between the test days. Blood will be collected via a catheter before and up-to five hours after protein consumption. Wellbeing, health complaints or other adverse effects will be collected via a short questionnaire during each test day. After each test day gastrointestinal complaints are collected via an online questionnaire.

Detailed description

Barley rice protein is extracted from brewer spent grains (BSG), which is the most voluminous by-product of the brewing industry. Until now, BSG has been mainly used for animal feed or is directly discarded, which is an enormous waste of resources and causes serious environmental pollution. BSG is rich in cellulose and non-cellulosic polysaccharides, lignin, and proteins. The protein fraction of BSG contains a relatively high content of the essential amino acid, lysine, in comparison to other cereal products. Because of its high nutritional content, BSG can be applied in human food products for fortification. The digestion characteristics of barley rice protein are not known, but essential to evaluate their future potential as a sustainable protein source. The primary objective is to estimate the degree of digestibility of barley rice protein by measuring post-prandial amino acid uptake kinetics, and compare this to pea protein and a benchmark protein (whey). Secondary objectives are to assess the effects on blood glucose and insulin levels. The study is a randomized, cross-over, double blind, controlled trial. Three different treatments, all representing a 20g protein load, will be evaluated with a washout period of minimum one week between the test days. Blood will be collected via a catheter before and up-to five hours after protein consumption. Wellbeing, health complaints or other adverse effects will be collected via a short questionnaire during each test day. After each test day gastrointestinal complaints are collected via an online questionnaire.

Conditions

Interventions

TypeNameDescription
OTHERBarley rice protein concentrate shakeAt one out of three test days barley rice protein concentrate powder will be mixed with water to obtain a shake, representing a 20g protein load.
OTHERPea protein concentrate shakeAt one out of three test days pea protein concentrate powder will be mixed with water to obtain a shake, representing a 20g protein load.
OTHERWhey protein concentrate shakeAt one out of three test days whey protein concentrate powder will be mixed with water to obtain a shake, representing a 20g protein load.

Timeline

Start date
2022-06-09
Primary completion
2022-07-14
Completion
2022-07-14
First posted
2022-06-21
Last updated
2022-07-18

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05426122. Inclusion in this directory is not an endorsement.